Clinical Trial Detail

NCT ID NCT01741727
Title A Study of ABT-414 in Subjects With Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie (prior sponsor, Abbott)
Indications

Advanced Solid Tumor

lung squamous cell carcinoma

Therapies

Depatuxizumab mafodotin

Age Groups: adult

No variant requirements are available.